Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

✍ Scribed by T. Mazard; M. Ychou; S. Thezenas; S. Poujol; F. Pinguet; A. Thirion; J. P. Bleuse; F. Portales; E. Samalin; E. Assenat

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 197 KB
• Volume: 69
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-011-1764-z